• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SPI PDS+ UNI VIO 6IN 2-0 S/A SH; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SPI PDS+ UNI VIO 6IN 2-0 S/A SH; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE Back to Search Results
Catalog Number SXPP1B415
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/21/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint #
=
> (b)(4) h6.Component code: g07002 - device not returned attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.- when did the suture break (in the package, during removal from the package, during handling before use on patient or during use on the patient)? please specify - procedure name and date? this report is being submitted pursuant to the provisions of 21 cfr part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
It was reported that a patient underwent an unknown procedure on an unknown date and barbed suture was used.The suture cut off while using.The procedure was completed successfully.No adverse patient consequences were reported.Additional information was requested.
 
Additional Manufacturer Narrative
(b)(4), this report is being submitted pursuant to the provisions of 21 cfr part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A review of the batch manufacturing records was conducted, and no related non-conformances were identified.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 4/29/2024.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 component code: g07002 no device problem found.Additional information: d9, h3, h6.H3 investigational summary: the product was returned to ethicon for evaluation.The returned sample determined that it was received twenty unopened samples that pertains to product code sxpp1b415 were returned.Upon initial inspection, of the samples, no external damages were observed on the packets.As per the sampling plan, a visual inspection was performed on thirteen samples, the packets were opened, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand and no issues related to breakage sutures or anomalies were observed during the evaluation.A functional test was performed using instron equipment and tensile force was above the minimum requirements.The event described could not be confirmed as the device performed without any defect noted.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Additional h3 investigational summary: the product was returned to ethicon for evaluation.Visual analysis of the returned product determined that it was received, one needle-suture piece outside its packaging that pertains to product code sxpp1b415.During visual inspection of the returned sample, body fluids and marks that appear to be caused by a surgical instrument were observed on the body needle.The suture piece was examined, and the extreme was to be cut probably caused by a surgical instrument.In addition, body fluids were noted on the strand.The other section of the suture was not returned for analysis.The product code sxpp1b415 contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Additional h3 investigational summary: the product was returned to ethicon for evaluation.Visual analysis of the returned product determined that it was received, one needle-suture piece outside its packaging that pertains to product code sxpp1b415.During visual inspection of the returned sample, body fluids and marks that appear to be caused by a surgical instrument were observed on the body needle.The suture piece was examined, and the extreme was to be cut probably caused by a surgical instrument.In addition, body fluids were noted on the strand.The other section of the suture was not returned for analysis.The product code sxpp1b415 contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Additional h3 investigational summary: the product was returned to ethicon for evaluation.Visual analysis of the returned product determined that it was received, one strand in two sections outside its packaging that pertains to product code sxpp1b415.During visual inspection of the returned sample, body fluids and marks that appear to be caused by a surgical instrument were observed on the body needles.The suture pieces were examined, and the extremes were to be cut probably caused by a surgical instrument.In addition, body fluids were noted on the strand.The product code sxpp1b415 contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Additional h3 investigational summary: the product was returned to ethicon for evaluation.The returned sample determined that it was received, one opened sample that pertain to the product code sxpp1b415.In order to evaluate the condition of the returned sample, the suture was dispensed without problems and examined along the strand no anomalies or breakage suture was observed during the evaluation.The product code sxpp1b415 contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined and the functional test could be performed.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SPI PDS+ UNI VIO 6IN 2-0 S/A SH
Common Device Name
SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km 8.3
san lorenzo PR 00754
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key17962050
Report Number2210968-2023-07986
Device Sequence Number15153476
Product Code NEW
UDI-Device Identifier10705031235885
UDI-Public10705031235885
Combination Product (Y/N)Y
Initial Reporter CountryKS
PMA/510(K) Number
K150670
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2025
Device Catalogue NumberSXPP1B415
Device Lot NumberTCBAZZ
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer12/13/2023
04/08/2024
Initial Report FDA Received Date10/18/2023
Supplement Report FDA Received Date12/13/2023
04/29/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/04/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-